Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid to reduce bleeding during pacemaker implantation in anticoagulated patients
2019-002118-37Phase 3Active
- Sponsor
- Rafael Blancas-Gómez Casero
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in conduction defect comparing Topical tranexamic acid with Topical placebo/control (2 arms). Primary endpoint: Bleeding events. Started Dec 2019; status: active.
02
Drugs
tranexamic acid
03
Conditions
conduction defect
Beyond the preview
Go deeper on 2019-002118-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002118-37.